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1104O-25]p~O~rammedCell*a*~in~~~~ni~Hea~~ail”~e:
Deteotion,CheracterizstionandClinical
Correlations
M.R. Mehra, H.O. Ventura, J. Szakace, F.W.Smart, D.D. Stapleton,
R.V. Milani. Ochsner Medical Institutions, New Orleans, LA, USA
Becfrground:Pre-apoptosis, anearly manifestationof genetically prcgremmad
cell demise, is characterized by the presence of nuclear DNA fragmentation,
and is postulated as an underlying mechanism that mediates adverse ven-
tricular remodeling. Purpose: We sought to i) establish the prasence of
pre-apoptosis; ii) charecteriza the best method for identifying pre-apoptosis;
and iii) explore its clinical and cytokine associations (Tumor Necrosis Factor-
alpha). Metfroda: Seventeen explanted hearts obtained at the time of cer-
diactrsnsplantation (13 ischemiccardiomyopathy; 4dilated cardiomyopathy)
were examined using the terminal deoxynucleotidyl transfarase mediated
dUTP nick end labeling (TUNEL) technique in situ. These findings were then
compared to the DNA Iaddering technique by gel elactrophoresis. Further
correlations were performed between levels of circulating Tumor Necrosis
Factor-alpha (TNF-alpha) and the number of pre-apoptotic cells per slide.
Resuffs:The TUNELmethrrd identified the presence of DNAfragmentation in
all tissue specimens available for analysis (100%), irrespective of etiology of
hearf failure. Conversely, the DNA Iaddering method detected pre-apoptosis
in only 6 samples (40Yo). Furthermore, there was no significant mrrelation
between circulating TNF-alpha levels (mean 32.2 + 3.9 Pg/ml), elevated in
all 17 patients, and the number of pre-apoptotic cells per slide examined
by TUNEL (r = 0.21; p = ns). Inferences: This investigation demonstrates
that 1) genetically programmed cell death (pre-apoptosis) is present in the
end-stage ventricle irrespective of etiology of cardiomyopathy; 2) the TUNEL
method is more aensitive than DNAladdering technique in characterizationof
pra-apoptosia and should be preferred; and 3) no significant correlation was
found between the degree of pre-apoptosis and tumor necrosis factor-alpha
elaboration in terminal heart failure.
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OxidsSynthesisin ExperimentalCongestive
HeartFailure
Q.Feng, X. Lu, A. Pettaraeon,T. Hedner, R.L. Kline, J.M.O. Arnold.
University of Western Ontario, Canada, Unive@ of Gothenburg, Sweden
Asymmetric dimethylarginine (ADMA) is an important endogenous substance
with potant inhibitory actions on nitric oxide (NO) synthesis. However, its role
in congestive heart failure (CHF) has not been described. The present study
was dasignad to determine circulating ADMA levels and NO mediated va-
aodilation in CHF. CHF was induced in rats by coronafy artery ligation (n
. 24). Sham-operated rats sewed as normal controls (n = 22). In isolated
aottic rings praconstricted with prostaglandin Fh, decreased endothelium-
dependent relaxation to acetylcholine was demonstrated (p < 0.01) and
completely restored by L-arginine treatment (300 MMfor 15 min in a organ
bath) in CHF (p c 0.01) while endothalium-independent relaxation to nitro-
prueeide was not altered (p = n.s.). Plasma Ievals of ADMA measured by
high performance liquid chromatography were significantly increased in rats
with CHF (0.94& 0.05 wmoill) compared with sham-operated controis (0.75
& 0.06 wmol/1,p e 0.05). Glomerular filtration rate (GFR) meaauradby inulin
clearance was negatively correlated with plasma levels of ADMA (r = -0.65,
p < 0.05). GFR was similar between CHF and sham-operated rats (p = n.s.).
Corrc/usions:The reau!tsdemonstrate that an endoganous NO synthesis
inhibitor ADMA is increased Inthe circulation of rats with CHF.The increased
plasma levels of ADMA with a normal GFR may suggest the possibility
of increased ADMA production in CHF which may contribute to decreased
endothelium-dependent relaxation. Aa this is restored by L-arginine, it sug-
gests that the effects of ADMA may be competitively inhibited.
m104027 CardiomyocytesFromInfsrctedRatHesrtMsnifestFunctionalDown-reaulstionof the
ArginineVasopressin-VlaRe;sptor
Y. Chandrashekhar, D.S. Liu, A.J. Prahash, S. Sen, 1.S.Anand. VAMerfkal
CenteL Minneapolis, MN, USA
Congestive heart failure (CHF) is associated with neurohormonal activation
& receptor down-regulation, which significantly influancas cardiovascular
function. Whereas Arginine Vasopressin (AVP) ia increased in CHF with
important cardiovascular effects, it is unclear if cardiac AVP receptors are
down-regulated. Since cardiomyocyfes bear functional AVP-Vla receptors
which mediate inotropy,we compared effects of a spacific Via agonist (AK-3-
33; 10-9-10-7 M)oncontractile function (video edge detection) & intracellular
calcium transients [Ca]i kinetics (FURA 2AM) in 22 myocytes from sham
operatad (S) rats (n =5) & compared them with 24 cells from rats (n =5) 8
weeks after an anterior infarct (Ml, LV developad pressure 135 + 3 vs 115 &
4 mmHg & LVEDP3.3 + 0.5 VS21 + 2 mmHg; S vs Ml respectively). AK-3-33
caused a dose dependent increase in % shortening & peak [Ca]i in myocytes
from S. This effect was significantly reduced in Ml. Similar differences were
seen in velocity of contraction & relaxation and in the rate of change in
[Ca]i (all p < 0,001). The inotropic effects of extracellular Ca++ (1 to 6 mM),
however, were no different.
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These data suggest for the first time that the AVP-Vla receptors on
cardiomyocytes isolated from rats with Ml are “functionally down-regulated”
while the contractile response to a non-specific inotrope is presewed.
11040-28]SkeletalMuS~le@-AdrenOreCeptorSChangesin
ChronicHeartFailure:A BeneficialEffectof
@-BlockadeTherapy
Z. Chati, C. Michel, P.M.Mertes, F.Zannad. Department of Cardiology
University of Nanc~ France
i%adrenoreceptors (6-AR) Changes in tha skeletal muscle may Potentially
contribute to the oxidative and glycolyfic metabolic abnormalities obsewad
in chronic hearf failure (CHF). Previous studies have shown that ~-blocker
treatment maintained exercise capacity in patients with CHF. To investigate
whether similar effects may occur in the skeletal muscle, we etudied skeie-
tal muscle B-AR in 14 mal Wistar rats 12-14 wk after coronary ligation
(CL) and in 14 sham operated rats. Both groups were compared with a
group of 9 rats with CL received proprenolol 4 wk after CL procedure (BCL).
We investigated skeletal muscle P-AR in the soleus (oxidative), geetrecne-
mius (glycogenolytic), and vastus Iateralia (intermediate) muscles by [1251]
Iodocyanopindolol (ICYP) radioligand binding. Infarct size were large (CL: 41
+ 0.03; flCL: 50 + 0.02%). There were no significant differences in plaama
and skeletal muscle norepinephrine between groups. Although B-AR affin-
iv (kd) was similar in the 3 groups, P-AR density (ftmax) was significantly
affected in CL and l?CLgroups compared to sham group.
Soleustrmax(fMlmar)rotein) Gastrocnemiua VastuaIaterells
CL S.8& 2.9*t 26.9& 7.2* 14,9*4.3*t
BCL 31.9+6.6” 24.2+ 6.1* 4t,8+ 8.5*
Shsm 22.1* 7.1 4.2k 1,7 8.1+ 1.3
*P< 0.05relativatoShsm,tP c 0.05relativeto 9CL
Our findings demonstrate that the decrease in the B-AR density in the
oxidativeskeletel muscle type in CLgroupcould be prevented byproprenoiol.
This study suggasts that ~-blockade therapy in experimental i8chemic heart
failure may be beneficial and may explain the improvement in exercise
capacity obsewed in previous atudies.
m104029 Downregulatlonof a-and Upregulationof@-MyosinHeavyChainIn Intact,FailingHumeri
Ventricles
B.D. Lowes, W.A. Minobe, W.T.Abraham, R.L. Roden, J.D. Port,
E.M. Gilbert, P.Lerrebee, M.R. Bristow. Division of Cardiolog~ LJnivensityof
Colorado Cardiovascular Institute, Boulder and Denvc%CO, USA
Previous studies performed in limited numbers of human haarts obtained
under less than ideal conditions reported that adult human ventricular my-
ocardium contained only a “negligible” amount of the a-, fast contracting
MHC isoform. Additionally, the methodology for quantitating MHC isoform
gene expression has recently been improved by advances euch as quantits-
